Clinical Trial Update: Tau PET Outcomes With Anti-amyloid Immunotherapies [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports Tau PET outcomes for anti-amyloid immunotherapies. The study includes participants with mild cognitive impairment, mi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Dementia

Snippet

Sponsor: Mayo Clinic | Conditions: Cognitive Impairment, Mild, Dementia, Mild | Phase 2 | Status: ENROLLING_BY_INVITATION